Risk factors for methicillin-resistant Staphylococcus aureus bacteremia: A multicenter matched case-control study
Abstract
Introduction: Methicillin-resistant Staphylococcus aureus is a frequent pathogen at critical care services. Its presence leads to increased hospital stays and mortality risk in patients with bacteremia. However, the etiology of this resistance marker has not been fully studied.
Objective: To identify risk factors associated with the emergence of methicillin-resistant S. aureus bacteremia in critically ill patients treated at intensive care units in Bogotá, Colombia.
Materials and methods: We conducted a retrospective paired case-control study, nested in a cohort of patients diagnosed with S. aureus bacteremia and treated at intensive care units between 2006 and 2008 in Bogotá. Cases were patients with positive blood culture to methicillin resistance, matched in a 1:1 ratio with methicillin-sensitive controls isolated from the same institution and hospitalization year. We used conditional logistic regression to analyze the risk factors associated with the presence of resistance, with emphasis on prior antibiotic therapy.
Results: We included 372 patients with S. aureus bacteremia. Factors such as the use of pre-hospital devices: vascular (OR=1.986, 95% CI 1.038 to 3.801) and urinary (OR=2.559, 95% CI: 1.170 to 5.596), along with the number of previously used antibiotics, were associated with the emergence of resistance. The number of antibiotics used previously was determined to have a gradient effect, particularly carbapenems.
Conclusions: The rational use of antibiotics and surveillance of exposure to surgical procedures or use of invasive devices are interventions that could diminish the emergence of methicillin-resistant S. aureus bacteremia causes.
Downloads
References
World Health Organization. Antimicrobial resisteance, global report on surveillance. Geneva; WHO: 2014. Date of access: December 15, 2015. Available from: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf
Cavalcanti SM, França ER, Cabral C, Vilela MA, Montenegro F, Menezes D, et al. Prevalence of Staphylococcus aureus introduced into intensive care units of a University Hospital. Braz J Infect Dis. 2005;9:56-63. http://dx.doi.org/10.1590/S1413-86702005000100010
Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592-8. http://dx.doi.org/10.1086/367653
Whitby M, McLaws ML BG. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: A meta-analysis. Med J Aust. 2001;175:264-7.
Warren DK, Guth RM, Coopersmith CM, Merz LR, Zack JE, Fraser VJ. Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2006;27:1032-40.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55. http://dx.doi.org/10.1093/cid/ciq146
Castillo JS, Leal AL, Cortés JA, Álvarez CA, Sánchez R, Buitrago G, et al. Mortality among critically ill patients with bacteremia: A multicenter cohort study in Colombia Study setting. Rev Panam Salud Pública. 2012;32:343-50. http://dx.doi.org/10.1590/S1020-49892012001100004
Arias C a, Rincón S, Chowdhury S, Martínez E, Coronell W, Reyes J, et al. MRSA USA300 clone and VREF--a U.S.-Colombian connection? N Engl J Med. 2008;359:2177-9. http://dx.doi.org/10.1056/NEJMc0804021
Ho KM, Robinson JO. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: A case control study. Anaesth Intensive Care. 2009;37:457-63.
Porto JP, Santos RO, Pinto P, Filho G, Ribas RM. Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA. Rev Soc Bras Med Trop. 2013;46:713-8. http://dx.doi.org/10.1590/0037-8682-0199-2013
Vidal PM, Trindade PA, García TO, Pacheco RL, Costa SF, Reinert C, et al. Differences between “classical” risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV. Infect Control Hosp Epidemiol. 2009;30:139-45. http://dx.doi.org/10.1086/593954
Carnicer-Pont D, Bailey KA, Mason BW, Walker AM, Evans MR, Salmon RL. Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: A case-control study. Epidemiol Infect. 2006;134:1167-73. http://dx.doi.org/10.1017/S0950268806006327
Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother. 2008;52:1430-7. http://dx. doi.org/10.1128/AAC.01538-07
Cortés JA, Leal AL, Montañéz AM, Buitrago G, Castillo JS, Guzmán L. Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles. Braz J Infect Dis. 2014;17:346-52. http://dx.doi.org/10.1016/j.bjid.2012.10.022
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32. http://dx.doi.org/10.1016/j.ajic.2008.03.002
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40: 373-83.
Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33:1538-48.
Greenland S, Schwartzbaum JA, Finkle WD. Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol. 2000;151:531-9.
Li X, Song X, Gray R. Comparison of the missing-indicator method and conditional logistic regression in 1:m matched case-control studies with missing exposure values. Am J Epidemiol. 2004;159:603-10. http://dx.doi.org/10.1093/aje/kwh075
StataCorp. Stata Data Analysis ans Statistical Software 2011. College Station, TX: StataCorp LP; 2012.
GraphPad Software, Inc. GraphPad Software. La Jolla: GraphPad Software, Inc.; 2012.
Jonas D, Meyer E, Schwab F, Grundmann H. Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units. Infect Control Hosp Epidemiol. 2008;29:350-7. http://dx.doi.org/10.1086/528811
Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A sys-tematic review and meta-analysis. J Antimicrob Chemother. 2008;61:26-38. http://dx.doi.org/10.1093/jac/dkm416
Tacconelli E, De Angelis G, Cataldo MA, Mantengoli E, Spanu T, Pan A, et al. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: A hospital population-based study. Antimicrob Agents Chemother. 2009;53:4264-9. http://dx.doi.org/10.1128/AAC.00431-09
Olarte NM, Valderrama IA, Reyes KR, Garzón MI, Escobar JA, Castro BE, et al. Colonización por Staphylococcus aureus resistente a la meticilina en una unidad de cuidados intensi-vos de adultos de un hospital colombiano: caracterización fenotípica y molecular con detección de un clon de circulación en la comunidad. Biomédica. 2010;182:353-61. http://dx.doi.org/10.7705/biomedica.v30i3.269
Escobar-Pérez JA, Castro BE, Márquez-Ortiz RA, Gaines S, Chavarro B Moreno J, et al. Aislamientos de Staphylococcus aureus sensibles a meticilina relacionados genéticamente con el clon USA300, ¿origen de los aislamientos SARM de genotipo comunitario en Colombia? Biomédica. 2014;34(Suppl.1):124-36. http://dx.doi.org/10. 7705/biomedica.v34i0.1661
Some similar items:
- Carmelo José Espinosa, Jorge Alberto Cortés, Juan Sebastián Castillo, Aura Lucía Leal, Systematic review of antimicrobial resistance among Gram positive cocci in hospitals in Colombia , Biomedica: Vol. 31 No. 1 (2011)
- César A. Arias, Marylin Hidalgo, Jinnethe Reyes, Ana María Cárdenas, Lorena Díaz, Sandra Ríncon, Natasha Vanegas, Paula Lucía Díaz, Elizabeth Castañeda, Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci , Biomedica: Vol. 28 No. 2 (2008)
- Mercedes Figueroa, Armando Cortés, Álvaro Pazos, Luis Eduardo Bravo, Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis , Biomedica: Vol. 32 No. 1 (2012)
- Jacqueline Chaparro, Moisés Wasserrnanz, Modification of a Radiometric Microtest to detect Plasmodium falciparum Resistance to Several Drugs , Biomedica: Vol. 19 No. 1 (1999)
- Jacqueline Chaparro, Moisés Wasserman, Comparison of in vitro technlques for the detection of Plasmodium falciparum resistance to drugs , Biomedica: Vol. 19 No. 2 (1999)
- Eliana P. Calvo, María O. Rojas, Jacqueline Chaparro, Moisés Wasserman, Expresion of the multiple drug resistance associated gene (pfMDR 1) in Colombian strains of Plasmodium falciparum , Biomedica: Vol. 19 No. 3 (1999)
- Nélida Muñoz, Clara Inés Agudelo, Maria Victoria Ovalle, María Helena Realpe, Edilma Jaramillo, Sandra Núñez, Martha Uzeta, Vianney Portilla, María del Pilar Crespo, María Elena Alvarez, Constanza Sabogal, Mercedes Cano, María Claudia Rodríguez, María Eugenia Peláez, Lesli Bruzón, Mileny Arregocés, Gloria Patricia Londoño, Gloria Inés Dussán, Liliana Patiño, Alix Robinson, Surveillance of serotypes and antimicrobial susceptibility of Salmonellaspp., Shigella spp. and Vibrio cholerae O1, 1997-1999 , Biomedica: Vol. 20 No. 3 (2000)
- Catalina de Bedout, Julio Ayabaca, Ricardo Vega, Matilde Méndez, Axel R. Santiago, María Lucrecia Pabón, Angela Tabares, Myrtha Arango, Angela Restrepo, Vance Newell, Evaluation of Candida species' susceptibility to fluconazole with the disk diffusion method. , Biomedica: Vol. 23 No. 1 (2003)
- Ernesto Montoro, Miguel Echemendía, Dihadenys Lemus, Antonio Marrero, María J. Llanes, José A. Valdivia, Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998. , Biomedica: Vol. 24 (2004): Suplemento 1
- Virgilio Galvis, Alejandro Tello, Alfredo Guerra, María Fernanda Acuña, Donaldo Villarreal, Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia , Biomedica: Vol. 34 (2014): Abril, Suplemento 1, Resistencia bacteriana

Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |